MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.

[1]  Xian Wang,et al.  Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers , 2019, Aging.

[2]  R. Bohle,et al.  4-miRNA Score Predicts the Individual Metastatic Risk of Renal Cell Carcinoma Patients , 2019, Annals of Surgical Oncology.

[3]  N. Cho,et al.  Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers , 2019, Computational and structural biotechnology journal.

[4]  R. Motzer,et al.  Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations. , 2017, Urologic oncology.

[5]  N. Seki,et al.  Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma. , 2019, American journal of clinical and experimental urology.

[6]  William P. Parker,et al.  Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery. , 2018, European urology.

[7]  Chin-Lee Wu,et al.  Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis , 2018, Front. Physiol..

[8]  L. Guan,et al.  Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data. , 2018, Gene.

[9]  M. Soloway,et al.  Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[10]  R. Mehra,et al.  A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma. , 2017, European urology.

[11]  Zhiquan Hu,et al.  Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis , 2017, Cell cycle.

[12]  D. Canes,et al.  Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma , 2017, BJU international.

[13]  Tomohiko Ichikawa,et al.  Regulation of spindle and kinetochore‐associated protein 1 by antitumor miR‐10a‐5p in renal cell carcinoma , 2017, Cancer science.

[14]  B. Liang,et al.  A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysis , 2017, PloS one.

[15]  Chawnshang Chang,et al.  Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. , 2017, Cancer letters.

[16]  Y. Song,et al.  Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer , 2017, Genes & cancer.

[17]  H. Kume,et al.  Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma. , 2016, European urology focus.

[18]  Tomohiko Ichikawa,et al.  Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma , 2016, Journal of Human Genetics.

[19]  R. S. Huang,et al.  Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas , 2016, PloS one.

[20]  Hong-zhao Li,et al.  Establishment of a miRNA-mRNA regulatory network in metastatic renal cell carcinoma and screening of potential therapeutic targets , 2016, Tumor Biology.

[21]  Klaus Jung,et al.  Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma , 2016, PloS one.

[22]  Andreas Scorilas,et al.  Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype , 2016, Biological chemistry.

[23]  N. Seki,et al.  Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma , 2016, International journal of oncology.

[24]  Klaus Jung,et al.  Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p , 2016, PloS one.

[25]  E. Bass,et al.  Management of Renal Masses and Localized Renal Cancer: Systematic Review and Meta-Analysis. , 2016, The Journal of urology.

[26]  C. Kwak,et al.  Risk of metastasis for T1a renal cell carcinoma , 2016, World Journal of Urology.

[27]  Da-wei Cao,et al.  MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2. , 2015, International journal of clinical and experimental pathology.

[28]  Chawnshang Chang,et al.  Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status , 2015, Oncotarget.

[29]  Margarita Lopatin,et al.  A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies. , 2015, The Lancet. Oncology.

[30]  Jian Ma,et al.  let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma , 2015, World Journal of Surgical Oncology.

[31]  Meng Zhu,et al.  A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma , 2015, Journal of Cancer Research and Clinical Oncology.

[32]  N. Seki,et al.  Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma. , 2014, The Journal of urology.

[33]  J. Cheville,et al.  Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  M. Kattan,et al.  ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. , 2014, European urology.

[35]  D. Lindgren,et al.  The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. , 2014, European journal of cancer.

[36]  Karthik Devarajan,et al.  MicroRNA expression signatures of stage, grade, and progression in clear cell RCC , 2014, Cancer biology & therapy.

[37]  Subha Madhavan,et al.  Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs , 2014, PloS one.

[38]  K. Nathanson,et al.  Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activity. , 2014, Cancer discovery.

[39]  Marcus Stapf,et al.  MicroRNAs with Prognostic Potential for Metastasis in Clear Cell Renal Cell Carcinoma: A Comparison of Primary Tumors and Distant Metastases , 2014, Annals of Surgical Oncology.

[40]  J. Cheville,et al.  The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters , 2013, The American journal of surgical pathology.

[41]  J. Bishoff,et al.  Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. , 2013, The Journal of urology.

[42]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[43]  The Cancer Genome Atlas Research Network.  COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.

[44]  Lei Zhang,et al.  The complex roles of microRNAs in the metastasis of renal cell carcinoma. , 2013, Journal of nanoscience and nanotechnology.

[45]  R. Blaheta,et al.  MicroRNA-145 targets the metalloprotease ADAM17 and is suppressed in renal cell carcinoma patients. , 2013, Neoplasia.

[46]  C. Kwak,et al.  Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis , 2012, BJU international.

[47]  R. Dahiya,et al.  Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer , 2012, PloS one.

[48]  K. Schaser,et al.  Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas , 2012, International journal of biological sciences.

[49]  K. Chamie,et al.  Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. , 2012, The Journal of urology.

[50]  A. Poprach,et al.  Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients , 2012, Genes, chromosomes & cancer.

[51]  R. Figlin,et al.  Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis , 2012, PloS one.

[52]  Pierre I Karakiewicz,et al.  Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. , 2011, European urology.

[53]  George M Yousef,et al.  Accurate molecular classification of kidney cancer subtypes using microRNA signature. , 2011, European urology.

[54]  Antonio Alcaraz,et al.  MicroRNA in prostate, bladder, and kidney cancer: a systematic review. , 2011, European urology.

[55]  J. Patard,et al.  Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. , 2011, European urology.

[56]  R. Sylvester,et al.  A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. , 2011, European urology.

[57]  K. Junker,et al.  Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma , 2011, World Journal of Urology.

[58]  Huiqing Liu,et al.  Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma , 2010, BMC Systems Biology.

[59]  D. Welch,et al.  Metastamir: the field of metastasis-regulatory microRNA is spreading. , 2009, Cancer research.

[60]  Mauro Biffoni,et al.  The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.

[61]  B. Hollenbeck,et al.  Five‐year survival after surgical treatment for kidney cancer , 2007, Cancer.

[62]  Stephanie Daignault,et al.  Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect , 2006 .

[63]  D. Hosmer,et al.  Model‐Building Strategies and Methods for Logistic Regression , 2005 .

[64]  Claus Lindbjerg Andersen,et al.  Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.

[65]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.